Thu. 23 May 2024, 2:06am ET
Benzinga
Earnings, News
Calliditas Therapeutics (NASDAQ:CALT) reported quarterly losses of $(0.88) per share. This is a 163.47 percent decrease over losses of $(0.33) per share from the same period last year. The company reported $28.43 million in sales this quarter. This is a 55.21 percent increase over sales of $18.32 million the same period last year.